KFDA say, no safety problems with plasma fraction products.

The KFDA responded to the issues raised by Rep. Ko Gyeong-wha concerning the HIV infected blood preparations in the market on Sept. 5 that the plasma fraction products of the HIV injected blood had no any safety problems because most of virus should be eradicated in the manufacturing process.

The KFDA stated that 7.4 log/ml of viral counts in the blood of B or C hepatitis or AIDS patients an...